These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 2767116
1. Acute haemodynamic effects of ibopamine and dopamine on isovolumic relaxation. Bernardi L, Perlini S, Soffiantino F, Farilla C, Calciati A, Soldá PL, Paro M, Merlo L, Marchetti G, Finardi G. Eur J Pharmacol; 1989 May 30; 164(3):415-24. PubMed ID: 2767116 [Abstract] [Full Text] [Related]
2. Systemic and coronary hemodynamic actions of the novel inotropic agent, ibopamine, and the de-esterified metabolite and active form, epinine: relationship to left ventricular performance in the dog. Kopia GA, Ohlstein EH, Ruffolo RR. J Pharmacol Exp Ther; 1988 Aug 30; 246(2):434-40. PubMed ID: 3404441 [Abstract] [Full Text] [Related]
3. Assessment of the cardiohemodynamic effects of ibopamine, an orally-active dopamine analogue, in the anesthetized open-chest guinea pig and the isolated guinea pig atria. Matsui K, Imai S. Jpn J Pharmacol; 1986 Oct 30; 42(2):217-27. PubMed ID: 3795623 [Abstract] [Full Text] [Related]
4. Comparison of the alpha adrenoceptor activity of dopamine, ibopamine and epinine in the pulmonary circulation of the dog. Shebuski RJ, Fujita T, Smith JM, Ruffolo RR. J Pharmacol Exp Ther; 1987 Apr 30; 241(1):6-12. PubMed ID: 3033210 [Abstract] [Full Text] [Related]
5. Effect of dopamine, ibopamine, and epinine on alpha- and beta-adrenoceptors in canine pulmonary circulation. Shebuski RJ, Smith JM, Ruffolo R. Fundam Clin Pharmacol; 1989 Apr 30; 3(3):211-21. PubMed ID: 2548941 [Abstract] [Full Text] [Related]
6. Effects of ibopamine on systemic, pulmonary and regional hemodynamics. Experimental investigations in anesthetized dogs. Merlo L, Ghirardi P, Brusoni B, Mussini E, Marchetti G. Arzneimittelforschung; 1986 Feb 30; 36(2A):304-11. PubMed ID: 3707641 [Abstract] [Full Text] [Related]
7. The dopamine congener, ibopamine, in congestive heart failure. Ren JH, Unverferth DV, Leier CV. J Cardiovasc Pharmacol; 1984 Feb 30; 6(5):748-55. PubMed ID: 6209476 [Abstract] [Full Text] [Related]
8. Clinical pharmacology of ibopamine. Itoh H. Am J Med; 1991 May 29; 90(5B):36S-42S. PubMed ID: 1675550 [Abstract] [Full Text] [Related]
9. Comparison of the effects of the novel inotropic agent, ibopamine, with epinine, dopamine and fenoldopam on renal vascular dopamine receptors in the anesthetized dog. Nichols AJ, Smith JM, Shebuski RJ, Ruffolo RR. J Pharmacol Exp Ther; 1987 Aug 29; 242(2):573-8. PubMed ID: 2886644 [Abstract] [Full Text] [Related]
10. Analysis of the positive inotropic effect of ibopamine in the blood-perfused canine papillary muscle. Kawahara K, Inui J. J Cardiovasc Pharmacol; 1985 Aug 29; 7(2):316-20. PubMed ID: 2581086 [Abstract] [Full Text] [Related]
11. Inhibition of plasma cholinesterase prevents the dopamine DA-1 receptor mediated renal vasodilation produced by ibopamine. Nichols AJ, Shebuski RJ, Ruffolo RR. Eur J Pharmacol; 1987 Sep 23; 141(3):515-8. PubMed ID: 3666046 [Abstract] [Full Text] [Related]
13. Evaluation of the alpha and beta adrenoceptor-mediated activities of the novel, orally active inotropic agent, ibopamine, in the cardiovascular system of the pithed rat: comparison with epinine and dopamine. Nichols AJ, Ruffolo RR. J Pharmacol Exp Ther; 1987 Aug 23; 242(2):455-63. PubMed ID: 3039117 [Abstract] [Full Text] [Related]
14. Pharmacological profile of ibopamine. A summary of experiments on anaesthesized dogs. Marchetti GV. Cardiology; 1990 Aug 23; 77 Suppl 5():22-9. PubMed ID: 1980631 [Abstract] [Full Text] [Related]
17. A comparison of some renal and cardiovascular effects of a prostaglandin analog, SKF 82526 and ibopamine in anesthetized dogs. Seymour AA, Blaine EH. Arch Int Pharmacodyn Ther; 1984 Jun 23; 269(2):304-15. PubMed ID: 6148046 [Abstract] [Full Text] [Related]
19. Evaluation of acute hemodynamic effects and pharmacokinetic behaviour of ibopamine in patients with severe heart failure. De Vita C, Triulzi E, Devizzi S, Colombo G, Palvarini M, Pocchiari F, Pataccini R. Arzneimittelforschung; 1986 Feb 23; 36(2A):349-54. PubMed ID: 3707648 [Abstract] [Full Text] [Related]